---
figid: PMC8267646__ijms-22-07193-g004
figtitle: Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet
  Activation Modulating ox-LDL Pathways
organisms:
- Candida dubliniensis
- Olea europaea
- Myristica fragrans
- Candida dubliniensis CD36
- Coronilla valentina
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
pmcid: PMC8267646
filename: ijms-22-07193-g004.jpg
figlink: /pmc/articles/PMC8267646/figure/ijms-22-07193-f004/
number: F4
caption: 'Circulating PCSK9 can bind the CD36 receptor on platelets and activates
  the downstream signaling including NOX2 activation, ROS production, and platelet
  activation. PCSK9i modulate platelet function and oxidative stress both reducing
  NOX2 activation by preventing the interplay between free PCSK9 molecule and CD36
  receptor and reducing oxLDL effect on CD36 and LOX1. Green arrow: PCSK9i pathway.
  Red lines: PCSK9 and ox-LDL pathway. Abbreviation: PCSK9 inhibitors (PCSK9i); Thromboxane
  A2 (TxA2); soluble NOX2-derived peptide (sNOX2-dp), hydrogen peroxide (H2O2); low-density
  lipoprotein (LDL), oxidized-LDL (ox-LDL).'
papertitle: Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet
  Activation Modulating ox-LDL Pathways.
reftext: Vittoria Cammisotto, et al. Int J Mol Sci. 2021 Jul;22(13):7193.
year: '2021'
doi: 10.3390/ijms22137193
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: platelets | ox-LDL | PCSK9 | familial hypercholesterolemia | NOX2
automl_pathway: 0.9305004
figid_alias: PMC8267646__F4
figtype: Figure
redirect_from: /figures/PMC8267646__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8267646__ijms-22-07193-g004.html
  '@type': Dataset
  description: 'Circulating PCSK9 can bind the CD36 receptor on platelets and activates
    the downstream signaling including NOX2 activation, ROS production, and platelet
    activation. PCSK9i modulate platelet function and oxidative stress both reducing
    NOX2 activation by preventing the interplay between free PCSK9 molecule and CD36
    receptor and reducing oxLDL effect on CD36 and LOX1. Green arrow: PCSK9i pathway.
    Red lines: PCSK9 and ox-LDL pathway. Abbreviation: PCSK9 inhibitors (PCSK9i);
    Thromboxane A2 (TxA2); soluble NOX2-derived peptide (sNOX2-dp), hydrogen peroxide
    (H2O2); low-density lipoprotein (LDL), oxidized-LDL (ox-LDL).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL9
  - RPSA
  - MAPK1
  - PSMD7
  - TP63
  - ARHGEF2
  - RABEPK
  - LANCL1
  - EBNA1BP2
  - BRMS1L
  - ARMH1
  - H3P28
  - CYBB
  - OLR1
  - PCSK9
  - CD36
  - Lancl1
  - Il12b
  - Il9
  - Rpsa
  - Arhgef2
  - Ebna1bp2
  - Slc35f6
  - Cybb
  - Olr1
  - Pcsk9
  - Cd36
  - Scarb1
---
